Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

The Residency Report

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

iOpeners

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

Neurotech Pharmaceuticals announced the first commercial manufacturing, shipment, and surgical procedure of ENCELTO, the first and only FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2. 

First FDA-approved treatment for MacTel performed

Assistant professor at Emory Eye Center in Atlanta, Georgia

Q&A: Sruthi Arepalli, MD, discusses outcomes in patients with noninfectious uveitis requiring secondary lens implantation

New research reveals that increased physical activity significantly slows visual field loss in glaucoma patients, highlighting exercise as a potential protective factor.

Active lifestyle tied to reduced visual field decline in primary open angle glaucoma

PA5108 is a rod-shaped, biodegradable micro implant designed to significantly reduce IOP in patients with primary open-angle glaucoma consistently over 6 months.

PolyActiva enrolls first patient in phase 2b clinical trial of PA5108 ocular implant

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times – Clinical Insights for Eye Specialists

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Fort Myers, FL-Takayuki Akahoshi, MD, will present the 2004 John H. Sheets Memorial Lecture during the SEE Island Quality Sur-gery XVIII Seminar Feb. 28 to March 3.

Phaco prechop pioneer to speak at SEE seminar

Phaco prechop pioneer to speak at SEE seminar

Newsletter